Literature DB >> 8608409

Functional expression of the P-glycoprotein mdr in primary cultures of bovine cerebral capillary endothelial cells.

D Lechardeur1, D Scherman.   

Abstract

The P-glycoprotein mdr is expressed not only in tumoral cells, but also in nontransformed cells, including the specialized endothelial cells of brain capillaries which build up the blood-brain barrier. Since all previously identified blood-brain barrier markers are rapidly lost when cerebral capillary endothelial cells are maintained in primary culture, we have investigated whether P-glycoprotein (P-gp) would follow the same rule, in order to address the influence of the cerebral environment on the specific P-gp expression in the brain endothelium. As compared to freshly isolated purified cerebral capillaries, P-glycoprotein was detected by immunochemistry at a high level in 5-7 day primary cultures. In our culture conditions, P-glycoprotein was immunodetected at a lower molecular weight than that found in freshly isolated capillaries. Enzymatic deglycosylation led to the same 130 kDa protein for both fresh and cultured samples, suggesting that P-gp post-translational modifications were altered in primary cultures. However, studies on the uptake and efflux of the P-gp substrate [3H]vinblastine, and on the effect of various mdr reversing agents on the uptake and efflux, clearly indicated that the efflux pump function of the P-glycoprotein was maintained in primary cultures of bovine cerebral capillary endothelial cells. P-Glycoprotein may thus represent the first blood-brain barrier marker which is maintained in cerebral endothelial cells cultured in the absence of factors originating from the brain parenchyma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8608409     DOI: 10.1007/bf00757626

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  35 in total

1.  Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A.

Authors:  D J Begley; L K Squires; B V Zloković; D M Mitrović; C C Hughes; P A Revest; J Greenwood
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

2.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

3.  A routine procedure for estimating serum gamma-glutamyltranspeptidase activity.

Authors:  L Naftalin; M Sexton; J F Whitaker; D Tracey
Journal:  Clin Chim Acta       Date:  1969-11       Impact factor: 3.786

Review 4.  The cell biology of multiple drug resistance.

Authors:  W T Beck
Journal:  Biochem Pharmacol       Date:  1987-09-15       Impact factor: 5.858

5.  Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas.

Authors:  S A Pileri; E Sabattini; B Falini; P L Tazzari; F Gherlinzoni; M G Michieli; D Damiani; L Zucchini; M Gobbi; T Tsuruo
Journal:  Histopathology       Date:  1991-08       Impact factor: 5.087

6.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

Authors:  P M Chaudhary; I B Roninson
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

7.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.

Authors:  P Wils; V Phung-Ba; A Warnery; D Lechardeur; S Raeissi; I J Hidalgo; D Scherman
Journal:  Biochem Pharmacol       Date:  1994-10-07       Impact factor: 5.858

9.  The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa.

Authors:  S Hsing; Z Gatmaitan; I M Arias
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

10.  A cell culture model of the blood-brain barrier.

Authors:  L L Rubin; D E Hall; S Porter; K Barbu; C Cannon; H C Horner; M Janatpour; C W Liaw; K Manning; J Morales
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more
  4 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier.

Authors:  P J Gaillard; I C van der Sandt; L H Voorwinden; D Vu; J L Nielsen; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

4.  An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.

Authors:  Hans Christian Helms; Maria Hersom; Louise Borella Kuhlmann; Lasina Badolo; Carsten Uhd Nielsen; Birger Brodin
Journal:  AAPS J       Date:  2014-06-17       Impact factor: 4.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.